Biomarker IP after Prometheus: Patenting the Unpatentable

Posted by

SELECTBIO

In this tag-team presentation, two IP lawyers will discuss the latest trends in this evolving field: The Supreme Court decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc. shifted the biomarker IP landscape by raising the bar to obtain meaningful patent protection for diagnostic methods involving biomarker detection. We will review recent developments in patent law concerning diagnostic method claims, and the approaches we are currently using to successfully address the Prometheus standard.